Roback Figure 2.
Roback Figure 2. Proposed effects of anti-cytomegalovirus (CMV) vaccination (veDLI) on CMV, graft-versus-host disease (GvHD), and other adverse events after hematopoietic stem cell transplantation (HSCT).

Proposed effects of anti-cytomegalovirus (CMV) vaccination (veDLI) on CMV, graft-versus-host disease (GvHD), and other adverse events after hematopoietic stem cell transplantation (HSCT).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal